NASDAQ:TROW
T. Rowe Price Group, Inc.
- Stock
industry
Asset Managementexchange
NASDAQ Global Selectwebsite
www.troweprice.comipo date
Jan 04, 1986full time employees
7,868currency
USD
T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- Thomas Price Jr.
num employees
- 5001-10000
recent investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$320M | Series C - Lambda | — | 15-02-2024 | Lambda |
$254M | Series E - Freenome | — | 15-02-2024 | Freenome |
$112M | Series B - ProfoundBio | — | 13-02-2024 | ProfoundBio |
$145M | Series C - Lilac Solutions | — | 12-02-2024 | Lilac Solutions |
$101M | Series C - Odyssey Therapeutics | — | 05-12-2023 | Odyssey Therapeutics |
$105M | Venture Round - RefleXion Medical | — | 15-11-2023 | RefleXion Medical |
$10M | Venture Round - Apiture | Yes | 14-11-2023 | Apiture |
$40M | Convertible Note - Stash | Yes | 13-10-2023 | Stash |
$273M | Series C - Generate Biomedicines | — | 15-09-2023 | Generate Biomedicines |
$684.6M | Series I - Databricks | Yes | 14-09-2023 | Databricks |